“biosimilars” Archives

in
Entry Author Date Location
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others 03/27/20 San Diego
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis 11/06/19 Boston
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet 08/30/19 Boston
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount 03/04/19 Indiana
FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks 01/16/19 National
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Senators Grill HHS’s Azar on Drug Price Cuts That Have Yet to Come 06/26/18 National
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details 05/11/18 National
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
Biopharmaceutical Haiku 02/03/14 National
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
San Diego Life Sciences Roundup: Life’s M&A Deal, Santarus, & More 04/18/13 San Diego
Clash of the BioPharma Titans Looms Over Biosimilars 06/25/12 National
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 12/27/11 New York
Momenta, Baxter Team Up on Biosimilars 12/23/11 Boston
Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines 12/23/11 Boston
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs 12/19/11 National
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
Biogen Idec Boosts Biogenerics Strategy With $300M Samsung Joint Venture 12/06/11 Boston
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom 10/05/11 New York
Page 1 of 2 next page »